283 related articles for article (PubMed ID: 31760822)
1. Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease.
Fancellu G; Chand K; Tomás D; Orlandini E; Piemontese L; Silva DF; Cardoso SM; Chaves S; Santos MA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):211-226. PubMed ID: 31760822
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
[TBL] [Abstract][Full Text] [Related]
5. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
6. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug.
Chand K; Rajeshwari ; Candeias E; Cardoso SM; Chaves S; Santos MA
Metallomics; 2018 Oct; 10(10):1460-1475. PubMed ID: 30183790
[TBL] [Abstract][Full Text] [Related]
7. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
[TBL] [Abstract][Full Text] [Related]
8. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer´s disease therapy.
Hiremathad A; Chand K; Tolayan L; Rajeshwari ; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
J Inorg Biochem; 2018 Feb; 179():82-96. PubMed ID: 29182921
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
12. ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker.
Liu Z; Zhang B; Xia S; Fang L; Gou S
Eur J Med Chem; 2021 Feb; 212():112997. PubMed ID: 33189440
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
[TBL] [Abstract][Full Text] [Related]
15. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Cao Z; Song Q; Yu G; Liu Z; Cong S; Tan Z; Deng Y
Bioorg Med Chem; 2021 Apr; 35():116074. PubMed ID: 33640707
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
[TBL] [Abstract][Full Text] [Related]
17. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
[TBL] [Abstract][Full Text] [Related]
18. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
20. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
